Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism Bacterial DnaK inhibitors(Bacterial DnaK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Staphylococcus Aureus Infections | Preclinical | US | 06 Feb 2024 | |
Staphylococcus Aureus Infections | Preclinical | US | 06 Feb 2024 |